Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Genesis product seizure

This article was originally published in The Tan Sheet

Executive Summary

FDA seized two Bio-Genesis products, Latero-Flora and Flora-Balance, at the company's San Marcos, Calif. headquarters and San Bernardino, Calif. manufacturing facility on April 22. FDA tests revealed that the products in liquid form were contaminated with Pseudomonas, Flavobacterium and Bacillus bacteria, which the agency said "can cause severe or fatal infections in people with weakened immune systems." The products, which FDA said are promoted especially to chemotherapy, organ transplant, AIDS and long-term antibiotic patients, are marketed to aid "in resolving many immuno-suppressed conditions" and relieve symptoms of chronic fatigue syndrome, hay fever, athlete's foot and tonsillitis. The agency said it is still investigating the case and does not know how much of the nationally marketed products are still on store shelves
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082698

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel